TITLE

DIRECT-TO-CONSUMER GENETIC TESTS: Misleading Test Results Are Further Complicated by Deceptive Marketing and Other Questionable Practices

AUTHOR(S)
Kutz, Gregory
PUB. DATE
July 2010
SOURCE
GAO Reports;7/22/2010, preceding p1
SOURCE TYPE
Government Documents
DOC. TYPE
Article
ABSTRACT
The article focuses on the investigations made by the Government Accountability Office (GAO) regarding direct-to-consumer (DTC) genetic tests sold through the internet by DTC companies in the U.S. It says that the DTC companies were identified using deoxyribonucleic acid (DNA) tests. Furthermore, it says that the U.S. government has issued alert warnings and suggested that consumers should seek advises only from experts.
ACCESSION #
52739733

 

Related Articles

  • GAO report: Opinion leaders find little value in DTC advertising.  // Medical Device Daily;9/17/2007, Vol. 11 Issue 177, p6 

    The article discusses the highlights of a gathering convened by the U.S. Government Accountability Office (GA) earlier this year 2007 whose aim was to collect opinions from experts and opinion leaders on a variety of healthcare issues, ranging from direct-to-consumer (DTC) advertising to the...

  • Ethics Issues Still Dog Pharmaceutical Industry. Verschoor, Curtis C. // Strategic Finance;May2007, Vol. 88 Issue 11, p17 

    The author reflects on the U.S. pharmaceutical industry and feels it needs to rethink a number of strategies. The U.S. Government Accountability Office (GAO) did several studies to examine pharmaceutical industry issues. One GAO study found the number of new drugs produced has declined as the...

  • Prescription Drugs: GAO-08-758T.  // GAO Reports;5/ 8/2008, p1 

    The Food and Drug Administration (FDA) is responsible for overseeing direct-to-consumer (DTC) advertising of prescription drugs, which includes a range of media, such as television, magazines, and the Internet. If FDA identifies a violation of laws or regulations in a DTC advertising material,...

  • GAO report: FDA bureaucracy gums up DTC ad reviews. M. A. // Medical Marketing & Media;Jun2008, Vol. 43 Issue 6, p9 

    The article provides information about a U.S. Government Accountability Office (GAO) report regarding the U.S. Food and Drug Administration's (FDA) directives on direct-to-consumer (DTC) campaigns. A GAO report said that the FDA has failed to implement an effective system for tracking and...

  • Trends in: Direct-to-Consumer Ads. Drakulich, Angie // Pharmaceutical Technology;Jun2008, Vol. 32 Issue 6, p24 

    The article reports that the U.S. Food and Drug Administration (FDA) will be issuing fewer warning letters to companies concerning direct-to-consumer (DTC) advertising violations yearly. According to the Government Accountability Office (GAO), the reason for the change is an FDA-initiated...

  • DTC REPORT: Update.  // Medical Marketing & Media;Feb2007, Vol. 42 Issue 2, p28 

    The article reports developments related to the pharmaceutical industry in the U.S. Sepracor Inc. appointed Rob Ciappenelli as the new executive director of its central nervous system business. The Government Accountability Office criticized the Food and Drug Administration for lax in regulating...

  • Prescription Drugs: Improvements Needed in FDA's Oversight of Direct-to-Consumer Advertising: GAO-07-54.  // GAO Reports;12/14/2006, p1 

    The Food and Drug Administration (FDA) is responsible for overseeing direct-to-consumer (DTC) advertising of prescription drugs. If FDA identifies a violation of laws or regulations in a DTC advertising material, the agency may issue a regulatory letter asking the drug company to take specific...

  • FDA asked to require warnings on DTC ads for implanted devices. Long, Don // Biomedical Business & Technology;Jan2008, Vol. 31 Issue 1, p26 

    The article reports on a petition to require warnings on direct-to-consumer (DTC) advertising for implanted devices filed by the Washington-based Consumers Union (CU) to the U.S. Food and Drug Administration (FDA). The CU calls for the inclusion of warnings about the possibility of dangerous...

  • PHYSICIAN PARTICIPATION IN DIRECT-TO-CONSUMER GENETIC TESTING: PRAGMATISM OR PATERNALISM? Schleckser, Kathryn // Harvard Journal of Law & Technology;Spring2013, Vol. 26 Issue 2, p695 

    The article offers information on the significance of direct-to-consumer (DTC) genetics industry, which provides an online DNA testing model with the involvement or participation of physicians. It discusses several reasons for mandating physician participation including privacy concerns, fears...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics